文献速递神经肿瘤神经重症

恶性脑肿瘤术后30天死亡率:疫情前后全国队列对比

National Outcomes and Factors Associated with 30-Day Mortality in Malignant Brain Tumor Surgery: A Retrospective Cohort National Surgical Quality Improvement Program Analysis of Health System Resilience.
PubMed 文献 · World Neurosurg · 2026-07-24

该回顾性队列研究利用NSQIP数据库纳入13,716例幕上原发性恶性脑肿瘤开颅切除术成人患者,比较疫情前(2016-2019年,8830例)与疫情期间(2020-2021年,4886例)的30天死亡率。总体30天死亡率疫情前为3.1%、疫情期间为2.6%(P=0.087);多因素分析显示疫情期间手术与较低的死亡风险相关(OR 0.70,95%CI 0.55-0.88,P=0.0027),患者因素和术后并发症仍是死亡的主要驱动因素。

要点

  • 疫情期30天死亡率2.6%低于疫情前3.1%,但差异未达统计学显著(P=0.087)。
  • 多因素分析中疫情期手术与死亡风险降低独立相关(OR 0.70)。
  • 年龄、播散性癌症、术前白细胞升高及术后并发症与死亡显著相关。

核心结论

  • 与假设相反,COVID-19疫情期间幕上原发性恶性脑肿瘤手术后30天死亡率低于疫情前。
  • 无论医疗时代如何,患者自身因素和术后并发症仍是死亡率的主要驱动因素。

研究设计与样本

  • 回顾性队列研究,使用国家手术质量改进计划(NSQIP)数据库。
  • 纳入接受幕上原发性恶性脑肿瘤切除开颅术的成人患者,共13,716例(疫情前8830例,疫情期间4886例)。
  • 比较两个时期的30天死亡率,并用单因素和多因素logistic回归分析死亡相关风险因素。

主要发现

  • 总体30天死亡率疫情前为3.1%,疫情期间为2.6%(P=0.087)。
  • 多因素分析显示与死亡显著相关的因素包括时间段、年龄、播散性癌症、术前白细胞计数升高及术后并发症(肺炎、通气>48小时、卒中/脑血管意外)。
  • 多因素logistic回归中,疫情期间手术与较低的死亡风险相关(OR 0.70,95%CI 0.55-0.88,P=0.0027)。

临床怎么用

  • 围手术期应重点识别并管理患者特异性风险因素及术后并发症以降低死亡风险。
  • 研究结果为高需求压力下维持神经外科诊疗提供假设生成性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study investigates whether the incidence of 30-day postoperative mortality following supratentorial primary malignant brain tumor surgery differed significantly during the COVID-19 pandemic (2020-2021) compared to the prepandemic era (2016-2019). METHODS: This retrospective cohort study used the National Surgical Quality Improvement Program database to identify adult patients who underwent craniotomy for supratentorial primary malignant brain tumor resection. We compared 30-day mortality rates and analyzed risk factors associated with mortality in both periods using univariable and multivariable logistic regression. RESULTS: The study included 13,716 patients (8830 prepandemic; 4886 during the pandemic). Overall 30-day mortality rates were 3.1% prepandemic and 2.6% during the pandemic (P = 0.087). Multivariable analysis identified time period, age, disseminated cancer, increased preoperative white blood cell count, and postoperative complications (pneumonia, ventilation > 48 hours, and stroke/cerebrovascular accident) as factors significantly associated with mortality. Despite an expected increased odds of mortality during the COVID-19 period, surgery during the pandemic was associated with lower odds of mortality (odds ratio: 0.70, 95% confidence interval: 0.55-0.88, P = 0.0027) in multivariable logistic regression. CONCLUSIONS: Contrary to our hypothesis, 30-day mortality was lower during the COVID-19 pandemic. Patient-specific factors and postoperative complications remain the primary drivers of mortality regardless of the healthcare era. These results highlight the importance of perioperative risk mitigation and provide hypothesis-generating data for understanding how neurosurgical care can be maintained during periods of high demand that stress the healthcare system to its capacity.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Nguyen AV, Coughlin E, Mhaskar R, et al. National Outcomes and Factors Associated with 30-Day Mortality in Malignant Brain Tumor Surgery: A Retrospective Cohort National Surgical Quality Improvement Program Analysis of Health System Resilience. World Neurosurg. 2026. PMID: 42498224. doi:10.1016/j.wneu.2026.125212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。